Yuval Shaked

12.4k total citations · 1 hit paper
151 papers, 9.0k citations indexed

About

Yuval Shaked is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yuval Shaked has authored 151 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 81 papers in Molecular Biology and 52 papers in Cancer Research. Recurrent topics in Yuval Shaked's work include Angiogenesis and VEGF in Cancer (50 papers), Cancer Cells and Metastasis (42 papers) and Cancer, Hypoxia, and Metabolism (39 papers). Yuval Shaked is often cited by papers focused on Angiogenesis and VEGF in Cancer (50 papers), Cancer Cells and Metastasis (42 papers) and Cancer, Hypoxia, and Metabolism (39 papers). Yuval Shaked collaborates with scholars based in Israel, Canada and United States. Yuval Shaked's co-authors include Robert S. Kerbel, Francesco Bertolini, Shan Man, Patrizia Mancuso, Daniel J. Hicklin, Urban Emmenegger, Christina R. Lee, Michael Timaner, Ping Xu and Chris Folkins and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yuval Shaked

148 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics

2024 108 citations Jai Prakash, Yuval Shaked Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuval Shaked Israel	55	4.8k	4.3k	3.0k	1.4k	1.2k	151	9.0k
Anna C. Obenauf Austria	25	4.1k 0.9×	4.0k 0.9×	2.3k 0.8×	2.1k 1.5×	1.9k 1.6×	37	9.0k
Anne‐Marie Mes‐Masson Canada	50	4.4k 0.9×	2.7k 0.6×	1.9k 0.6×	1.3k 0.9×	1.2k 1.0×	272	9.1k
Yves A. DeClerck United States	55	3.7k 0.8×	4.1k 0.9×	4.3k 1.4×	1.5k 1.0×	774 0.7×	127	9.1k
Paula D. Bos United States	17	5.1k 1.1×	4.2k 1.0×	3.5k 1.2×	1.5k 1.1×	1.3k 1.1×	33	9.5k
Mauro Biffoni Italy	42	6.8k 1.4×	5.7k 1.3×	4.4k 1.5×	1.2k 0.9×	956 0.8×	110	11.6k
Justin M. Balko United States	50	5.1k 1.1×	6.1k 1.4×	2.5k 0.8×	2.7k 1.9×	2.3k 1.9×	152	11.5k
Muhammad Al‐Hajj United States	14	5.7k 1.2×	7.9k 1.8×	3.1k 1.0×	842 0.6×	895 0.8×	19	10.6k
Pascal Finetti France	52	4.7k 1.0×	4.9k 1.1×	3.5k 1.2×	1.5k 1.1×	1.3k 1.1×	175	9.8k
Amit Maity United States	45	3.4k 0.7×	2.7k 0.6×	1.9k 0.6×	1.0k 0.7×	1.2k 1.0×	153	7.2k
Andrew P. Mazar United States	53	3.5k 0.7×	2.3k 0.5×	3.0k 1.0×	908 0.6×	884 0.8×	176	7.8k

Countries citing papers authored by Yuval Shaked

Since Specialization

Citations

This map shows the geographic impact of Yuval Shaked's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuval Shaked with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuval Shaked more than expected).

Fields of papers citing papers by Yuval Shaked

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuval Shaked. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuval Shaked. The network helps show where Yuval Shaked may publish in the future.

Co-authorship network of co-authors of Yuval Shaked

This figure shows the co-authorship network connecting the top 25 collaborators of Yuval Shaked. A scholar is included among the top collaborators of Yuval Shaked based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuval Shaked. Yuval Shaked is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Drori, Stavit, et al.. (2025). STIM-IP3R crosstalk regulates migration of breast cancer cells. The Journal of Cell Biology. 224(9). 1 indexed citations

Harel, Michal, Igor Puzanov, Ronan J. Kelly, et al.. (2025). Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications. Journal for ImmunoTherapy of Cancer. 13(5). e011427–e011427.

Barash, Uri, Inna Naroditsky, Marina Weissmann, et al.. (2024). Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization. Cell Death and Disease. 15(12). 894–894. 1 indexed citations

Prakash, Jai & Yuval Shaked. (2024). The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer Discovery. 14(8). 1375–1388. 108 indexed citations breakdown →

Goshen‐Lago, Tal, Moran Szwarcwort‐Cohen, Anat Reiner‐Benaim, et al.. (2021). Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors. Cancer Discovery. 11(10). 2430–2435. 37 indexed citations

Khan, Kabir A., Madeleine Benguigui, Ping Xu, et al.. (2020). Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer. npj Breast Cancer. 6(1). 29–29. 28 indexed citations

Beyar‐Katz, Ofrat, Anat Reiner‐Benaim, Irit Avivi, et al.. (2019). Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy. Molecular Cancer Research. 17(11). 2331–2340. 30 indexed citations

Timaner, Michael, Madeleine Benguigui, Ofrat Beyar‐Katz, et al.. (2018). Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells. Cancer Research. 78(5). 1253–1265. 83 indexed citations

Perlman, Or, Iris S. Weitz, Sarit Sivan, et al.. (2018). Copper oxide loaded PLGA nanospheres: towards a multifunctional nanoscale platform for ultrasound-based imaging and therapy. Nanotechnology. 29(18). 185102–185102. 14 indexed citations

10.

Shaked, Yuval, Elizabeth Pham, Santosh Hariharan, et al.. (2016). Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy. Cancer Research. 76(20). 5983–5993. 43 indexed citations

11.

Voloshin, Tali, Dror Alishekevitz, Limor Kaneti, et al.. (2015). Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis. Molecular Cancer Therapeutics. 14(6). 1385–1394. 60 indexed citations

12.

Alishekevitz, Dror, et al.. (2013). Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing. Molecular Cancer Therapeutics. 13(1). 202–213. 13 indexed citations

13.

Gingis‐Velitski, Svetlana, David Loven, Liat Benayoun, et al.. (2011). Host Response to Short-term, Single-Agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice. Cancer Research. 71(22). 6986–6996. 99 indexed citations

14.

Francia, Giulio, Yuval Shaked, Kae Hashimoto, et al.. (2011). Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis. Molecular Cancer Therapeutics. 11(3). 680–689. 33 indexed citations

15.

Schmid, Michael C., Christie J. Avraamides, Philippe Foubert, et al.. (2011). Combined Blockade of Integrin-α4β1 Plus Cytokines SDF-1α or IL-1β Potently Inhibits Tumor Inflammation and Growth. Cancer Research. 71(22). 6965–6975. 96 indexed citations

16.

Shaked, Yuval, Terence Tang, Jill Woloszynek, et al.. (2009). Contribution of Granulocyte Colony-Stimulating Factor to the Acute Mobilization of Endothelial Precursor Cells by Vascular Disrupting Agents. Cancer Research. 69(19). 7524–7528. 64 indexed citations

17.

Folkins, Chris, Yuval Shaked, Shan Man, et al.. (2009). Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1. Cancer Research. 69(18). 7243–7251. 292 indexed citations

18.

Voskas, Daniel, Yael Babichev, Jennifer Alami, et al.. (2008). An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice. Journal of Leukocyte Biology. 84(1). 59–67. 3 indexed citations

19.

Franco, Marcela, Shan Man, Urban Emmenegger, et al.. (2006). Targeted Anti–Vascular Endothelial Growth Factor Receptor-2 Therapy Leads to Short-term and Long-term Impairment of Vascular Function and Increase in Tumor Hypoxia. Cancer Research. 66(7). 3639–3648. 126 indexed citations

20.

Shaked, Yuval, Urban Emmenegger, Giulio Francia, et al.. (2005). Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide Is an Effective Long-term Chemotherapy Treatment Strategy. Cancer Research. 65(16). 7045–7051. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact